Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New analgesic drugs presented at 8th World Congress on Pain

Oct. 11, 1996

Calpain inhibitors from Fujirebio

Oct. 4, 1996

Astra NOS inhibitors as neuroprotectants

Oct. 4, 1996

Divalproex reduces cognitive deficits associated with lithium

Oct. 4, 1996

Genzyme-Diacrin joint venture for porcine neural cell products

Oct. 4, 1996

Spanish investigators report MAO inhibitors

Oct. 4, 1996

MRC scientists investigate estrogen's role in psychological disorders

Oct. 4, 1996

Novopharm authorized to market generic Prozac in same color

Oct. 4, 1996

Atypical antipsychotic receives approvals

Oct. 4, 1996

Genset and Johnson & Johnson collaborate in the area of schizophrenia

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.